CAPRICOR THERAPEUTICS, INC. Income Statement
CAPR / Health Care|15 years of annual SEC 10-K data (FY2011-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 15 fiscal years. All figures from audited SEC 10-K filings.
CAPRICOR THERAPEUTICS, INC. reported $0 in revenue and $105M in net loss for FY2025. Revenue has grown at a 24.0% compound annual rate over the past 13 years.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $22.3M | $25.2M | $2.6M | $244.9K | $310.3K | $1.7M | $1.7M | $2.7M | $4.0M | $5.5M | $4.8M | $503.2K | $2.0M | $1.4M |
| SG&A Expense | $23.7M | $14.9M | $12.8M | $10.4M | $7.6M | $5.5M | $4.9M | $4.9M | $4.8M | $4.9M | $4.4M | $3.0M | $2.2M | $1.4M | $2.1M |
| R&D Expense | $84.5M | $50.0M | $36.4M | $21.8M | $13.6M | $8.5M | $12.1M | $12.1M | $10.8M | $16.0M | $13.8M | $7.8M | $5.2M | $2.6M | $4.1M |
| Operating Income | -$108.1M | -$42.6M | -$24.1M | -$29.7M | -$20.9M | -$13.7M | -$15.3M | -$15.3M | -$12.9M | -$17.0M | -$12.6M | -$6.0M | -$6.9M | -$2.1M | -$4.9M |
| Interest Expense | - | - | - | - | - | - | - | $0 | $398.8K | $344.7K | $248.6K | $200.5K | $58.1K | $0 | $0 |
| Income Tax | $1.6K | $1.6K | - | - | - | - | - | - | - | - | - | - | - | $0 | - |
| Net Income | -$105.0M | -$40.5M | -$22.3M | -$29.0M | -$20.0M | -$13.7M | -$15.2M | -$15.2M | $2.4M | -$18.8M | -$12.9M | -$6.2M | -$8.9M | -$2.1M | -$1.1M |
| EPS (Basic) | -$2.26 | -$1.15 | -$0.83 | -$1.18 | -$0.87 | -$0.88 | - | - | $0.10 | -$1.01 | - | - | - | - | - |
| EPS (Diluted) | -$2.26 | -$1.15 | -$0.83 | -$1.18 | -$0.87 | -$0.88 | -$5.17 | -$0.52 | $0.09 | -$1.01 | -$0.81 | -$0.53 | - | -$0.13 | -$0.19 |
| Shares Outstanding | 57.4M | 45.6M | 31.1M | 25.2M | 24.2M | 20.6M | 3.1M | 31.4M | 26.3M | 21.4M | 16.3M | 11.7M | 10.5M | 39.7M | 34.6M |
| Operating Margin | - | -191.1% | -95.6% | -1163.9% | -8549.9% | -4412.6% | -917.0% | -917.0% | -482.4% | -424.6% | -228.6% | -125.7% | - | -103.3% | -361.7% |
| Profit Margin | - | -181.7% | -88.5% | -1137.4% | -8175.9% | -4401.9% | -908.9% | -908.9% | 91.2% | -470.3% | -233.0% | -129.9% | - | -101.9% | -84.9% |